Showing results (1941-1950 of 5,935) with videos related to
Sort By:
Pageof 594
The Prostate|June 8, 2001
Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivinN Xing, J Qian, D Bostwick, et al.The Prostate|February 19, 2000
Effects of tobacco smoke on tumor growth and radiation response of dunning R3327 prostate adenocarcinoma in ratsS Johansson, M Landström, L Bjermer, et al.The Prostate|February 19, 2000
Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activationM Marcelli, M Marani, X Li, et al.The Prostate|February 19, 2000
Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapyG P Murphy, A A Elgamal, M J Troychak, et al.The Prostate|August 9, 2001
Primary culture of microvascular endothelial cells from human benign prostatic hyperplasiaA Stachon, T Schlüter, M Köller, et al.The Prostate|August 9, 2001
Polymorphic repeats in the androgen receptor gene in high-risk sibshipsE A Miller, J L Stanford, L Hsu, et al.The Prostate|July 27, 1999
Cross talk between melatonin and TGFbeta1 in human benign prostate epithelial cellsA Rimler, H Matzkin, N ZisapelThe Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.The Prostate|July 27, 1999
Relationship of p21(WAF1) expression with disease-free survival and biochemical recurrence in prostate adenocarcinomas (PCa)F H Sarkar, Y Li, W A Sakr, et al.The Prostate|August 10, 1999
Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancerJ T Hsieh, K Earley, R C Pong, et al.Pageof 594